AIM ImmunoTech’s Ampligen Receives Clearance from FDA for Exportation to Argentina for the Treatment of Severe Chronic Fatigue Syndrome


Important Milestone to Commercial Launch in Argentina Achieved
OCALA, FL / ACCESSWIRE / September 24, 2019 / AIM ImmunoTech (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases - such as severe chronic fatigue syndrome (CFS) - has received clearance to export to Argentina from the U.S. Food and Drug Administration (FDA) its flagship drug Ampligen. In 2016, the company announced the approval of its New Drug Application (NDA) from Argentina's Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica (ANMAT) for the commercial sale of Ampligen for the treatment of CFS.
The FDA requires certain regulations be met in order to export a drug manufactured in the United States to a foreign country. In order to receive clearance to export to Argentina, AIM ImmunoTech submitted information on the drug approval processes and standards in Argentina and the issuance by ANMAT of its approval of Ampligen.
The FDA determined that the processes and standards applicable to drug approval in Argentina meet the requirements under section 802(b)(2) of the U.S. Federal Food, Drug and Cosmetic Act. Those requirements include expert review of safety and effectiveness, good manufacturing practice and quality controls, adverse experience reporting and control of drug labeling and promotion. To our knowledge, this is the first time in over ten years, and only the second time ever, the FDA has made this determination.
The FDA has informed the company that it intends to make public disclosure of its clearance with respect to the export of Ampligen to Argentina. The company believes that this disclosure may be posted on the FDA website or it may be published in the Federal Register.

Popular Posts in the Last 7 Days

Perplexity names the AIDS Paradigm 20

From Perplexity: A list of 20 things Rebecca Culshaw could say to a new generation of AIDS doctors and scientists to get them to go back to ground zero in 1981, start from scratch, and rethink everything about AIDS including the nosology, the epidemiology, causation, the virology, the demonization of critics, the demonization and scapegoating and criminalization of patients.

Perplexity on Rebecca Culshaw and David Ho

Perplexity writes a fantasy Joe Rogan interview with Rebecca Culshaw

Rebecca Culshaw in a time machine (from Perplexity)

Perplexity on AIDS and Chronic Fatigue Syndrome

Perplexity discusses David Ho's role in the HIV-negative case story exploded at the Amsterdam AIDS Conference in 1992

Perplexity on Neenyah Ostrom's reporting linking AIDS and Chronic Fatigue Syndrome

Rethinking AIDS Nosology in Light of Inflammation (from Perplexity)

Perplexity on Rebecca Culshaw's critics.

Popular Post in the Last 30 Days

Ablashi discusses HHV-6, AIDS, Alzheimer's, and Chronic Fatigue Syndrome

Oral Kaposi's Sarcoma looks like the Crimson Crescents in Chronic Fatigue Syndrome patients.

Was Judy Mikovits destroyed because her XMRV work would have ultimately shown HIV is a total fraud?

Popular Posts from the Last Year

Ablashi discusses HHV-6, AIDS, Alzheimer's, and Chronic Fatigue Syndrome

Oral Kaposi's Sarcoma looks like the Crimson Crescents in Chronic Fatigue Syndrome patients.

Why HIV should be referred to as "a red herring."

Dr. Rebecca Culshaw Smith's book is discussed on Twitter

All Time Most Popular Posts

Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research

Anthony Fauci was part of the gang that silenced and destroyed Judy Mikovits.

Was Judy Mikovits destroyed because her XMRV work would have ultimately shown HIV is a total fraud?

Is Chronic Fatigue Syndrome the other AIDS epidemic in the gay community?